Clinical Trials Logo
  1. Home
  2. Other
  3. NCT03914443

A Feasibility Trial of Nivolumab With Neoadjuvant CF or DCF Therapy for Locally Advanced Esophageal Carcinoma

Locally Advanced Esophageal Squamous Cell Carcinoma Clinical Trial

Official title:
A Feasibility Trial of Nivolumab With Neoadjuvant CF or DCF Therapy for Locally Advanced Esophageal Carcinoma FRONTiER Trial

Clinical Trial Summary

The main purpose of this study is to evaluate the safety of the neoadjuvant therapy, nivolumab with CF (5-FU, CDDP) or nivolumab with DCF (5-FU, CDDP, DTX), for locally advanced esophageal carcinoma.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT03914443
Study type Interventional
Source National Cancer Center, Japan
Contact
Status Active, not recruiting
Phase Phase 1
Start date May 7, 2019
Completion date March 1, 2024
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT05743504 - Immunotherapy With CCRT Followed by Surgery for Locally Advanced ESCC Patients Phase 1/Phase 2
Recruiting NCT05520619 - Combination of Tislelizumab and Chemoradiotherapy in Esophageal Cancer (EC-CRT-002) Phase 2
Recruiting NCT04602013 - Sintilimab Injection Combined With Concurrent CCRT in Locally Advanced Esophageal Squamous Cell Carcinoma Phase 2
Not yet recruiting NCT05522894 - AK104 Alone or in Combination With Chemotherapy in the First-line Treatment of ESCC Phase 2
Not yet recruiting NCT06426797 - Neoadjuvant Cadonilimab Combined With Anlotinib in Locally Advanced Resectable Esophageal Squamous Cell Carcinoma Phase 2
Active, not recruiting NCT06342167 - Efficacy and Safety of Concurrent PD-1 Inhibitor and Radiotherapy With Immunonutrition for Esophageal Squamous Cell Carcinoma Phase 2
Recruiting NCT06187597 - Consolidation of Toripalimab After Chemoradiotherapy in Elderly Esophageal Cancer (EC-CRT-007) Phase 2
Recruiting NCT05130684 - Neo-NTP-CRT for Locally Advanced ESCC Phase 2
Not yet recruiting NCT04888403 - Exploring the Safety and Effectiveness of Toripalimab Combined With Neoadjuvant Radiotherapy and Chemotherapy in the Locally Advanced Esophageal Squamous Cell Carcinoma Phase 2
Recruiting NCT03917966 - The Phase II Trial of SHR-1210 Combined With Preoperative Chemotherapy or Apatinib for Locally Advanced ESCC Phase 2
Not yet recruiting NCT06356688 - A Clinical Study on the Efficacy and Safety of Paclitaxel Polymer Micelles and Cisplatin Combined With Cadonilimab as a Neoadjuvant Therapy for Locally Advanced Esophageal Squamous Cell Carcinoma Phase 2